BACKGROUND: Breast care nurses (BCNs) are specialized caregivers in certified breast cancer center teams. The impact of a BCN's work remains unknown. PATIENTS AND METHODS: The role of BCN care was evaluated in a post-discharge mail survey of 360 patients. RESULTS: A total of 207 (87%) of 237 (66%) returned questionnaires were analyzed; 171 (83%) patients had BCN contact, 36 (17%) did not. The mean global quality of life scores (EORTC-QLQ-C30) were 66.3 for women with contact to a BCN versus 62.5 for women without such contact (p < 0.05). Women with a BCN contact had better results than women without (p < 0.001) for the following parameters: receipt of information material (84 vs. 64%), information about hospital procedures (93 vs. 72%) and treatment plan (91 vs. 63%), and knowledge of own tumor hormone receptor status (83 vs. 53%). Medication adherence correlated with the knowledge about the tumor hormone receptor status and was significantly higher in women having contact with a BCN (79 vs. 56%). The high recommendation rate (81%) reflects the high level of satisfaction with BCNs. A qualitative analysis of comments and suggestions identified aspects to improve BCN services. CONCLUSIONS: BCN improve satisfaction and treatment adherence in breast cancer patients.
BACKGROUND: Breast care nurses (BCNs) are specialized caregivers in certified breast cancer center teams. The impact of a BCN's work remains unknown. PATIENTS AND METHODS: The role of BCN care was evaluated in a post-discharge mail survey of 360 patients. RESULTS: A total of 207 (87%) of 237 (66%) returned questionnaires were analyzed; 171 (83%) patients had BCN contact, 36 (17%) did not. The mean global quality of life scores (EORTC-QLQ-C30) were 66.3 for women with contact to a BCN versus 62.5 for women without such contact (p < 0.05). Women with a BCN contact had better results than women without (p < 0.001) for the following parameters: receipt of information material (84 vs. 64%), information about hospital procedures (93 vs. 72%) and treatment plan (91 vs. 63%), and knowledge of own tumor hormone receptor status (83 vs. 53%). Medication adherence correlated with the knowledge about the tumor hormone receptor status and was significantly higher in women having contact with a BCN (79 vs. 56%). The high recommendation rate (81%) reflects the high level of satisfaction with BCNs. A qualitative analysis of comments and suggestions identified aspects to improve BCN services. CONCLUSIONS: BCN improve satisfaction and treatment adherence in breast cancerpatients.
Authors: L Cataliotti; C De Wolf; R Holland; L Marotti; N Perry; K Redmond; M Rosselli Del Turco; H Rijken; N Kearney; I O Ellis; A Di Leo; R Orecchia; A Noel; M Andersson; W Audretsch; N Bjurstam; R W Blamey; M Blichert-Toft; H Bosmans; A Burch; G Bussolati; M R Christiaens; M Colleoni; G Cserni; T Cufer; S Cush; J Damilakis; M Drijkoningen; P Ellis; J Foubert; M Gambaccini; E Gentile; F Guedea; J Hendriks; R Jakesz; J Jassem; B A Jereczek-Fossa; O Laird; E Lartigau; W Mattheiem; N O'higgins; E Pennery; D Rainsbury; E Rutgers; M Smola; E Van Limbergen; K von Smitten; C Wells; R Wilson Journal: Eur J Cancer Date: 2007-02-05 Impact factor: 9.162
Authors: H Pfaff; U-S Albert; R Bornemann; N Ernstmann; J Gostomzyk; M G Gottwik; G Heller; U Höhmann; U Karbach; O Ommen; M Wirtz Journal: Gesundheitswesen Date: 2009-10-05
Authors: Christian Jackisch; Michael Untch; Dimitrios Chatsiproios; Christiane Lamparter; Friedrich Overkamp; Werner Lichtenegger; Wolfgang Rönsberg; Christoph Thomssen; Gunter von Minckwitz; Ute-Susann Albert Journal: Breast Care (Basel) Date: 2008-04-25 Impact factor: 2.860
Authors: M Klinkhammer-Schalke; M Koller; C Ehret; B Steinger; B Ernst; J C Wyatt; F Hofstädter; W Lorenz Journal: Br J Cancer Date: 2008-08-05 Impact factor: 7.640
Authors: Caitlin C Murphy; L Kay Bartholomew; Melissa Y Carpentier; Shirley M Bluethmann; Sally W Vernon Journal: Breast Cancer Res Treat Date: 2012-06-12 Impact factor: 4.872
Authors: Ekim Ekinci; Salima Nathoo; Thushara Korattyil; Aisha Vadhariya; Hanna A Zaghloul; Polly A Niravath; Susan M Abughosh; Meghana V Trivedi Journal: J Cancer Surviv Date: 2018-02-02 Impact factor: 4.442
Authors: Sue P Heiney; Pearman D Parker; Tisha M Felder; Swann Arp Adams; Omonefe O Omofuma; Jennifer M Hulett Journal: Breast Cancer Res Treat Date: 2018-11-01 Impact factor: 4.872
Authors: Alison Harrow; Ruth Dryden; Colin McCowan; Andrew Radley; Mark Parsons; Alastair M Thompson; Mary Wells Journal: BMJ Open Date: 2014-06-12 Impact factor: 2.692
Authors: Leah K Lambert; Lynda G Balneaves; A Fuchsia Howard; Stephen K Chia; Carolyn C Gotay Journal: BMC Cancer Date: 2018-07-11 Impact factor: 4.430